Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic Helicobacter pylori Infection by D'Souza, Criselle et al.
 1 
Mucosal-associated invariant T cells orchestrate immunopathology and augment gastritis in 
chronic Helicobacter pylori infection 
Criselle D’Souza1,2, Troi Pediongco1, Huimeng Wang1, Jean-Pierre Y. Scheerlinck2, Lyudmila 
Kostenko1, Robyn Esterbauer1, Andrew Stent2, Sidonia B.G. Eckle1, Bronwyn S. Meehan1, Richard 
A. Strugnell1, Hanwei Cao1, Ligong Liu3,4, Jeffrey Y.M. Mak3,4, David P. Fairlie3,4, Jamie Rossjohn5,6,7, 
James McCluskey1, Alison L. Every2*, Zhenjun Chen1*, Alexandra J. Corbett1* 
 
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and 
Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia 
2Centre for Animal Biotechnology, Faculty of Veterinary and Agricultural Sciences, University of 
Melbourne, Victoria 3010, Australia 
3Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University 
of Queensland, Brisbane, Queensland 4072, Australia 
4Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The 
University of Queensland, Brisbane, Queensland 4072, Australia 
5Infection and Immunity Program and Department of Biochemistry and Molecular Biology, 
Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia 
6ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, 
Victoria 3800, Australia 
7Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff 
CF14 4XN, UK 
* joint senior authors. 
Corresponding authors; Dr Alexandra Corbett; ORCID 0000-0003-1618-4337 
corbetta@unimelb.edu.au Dr Zhenjun Chen; ORCID 0000-0003-1205-683X 
zhenjun@unimelb.edu.au 
Deleted: David P. Fairlie3,4, 
 2 
Running title: MAIT cells augment Helicobacter pylori-induced pathology 
 
SUMMARY 
Mucosal-associated invariant T cells produce pro-inflammatory cytokines in response to 
microbially-derived vitamin B2 metabolites, protecting against some human pathogens. We 
demonstrate that MAIT cells augment immunopathology in murine Helicobacter pylori infection, 
with implications for human infection and associated disease. 
 
ABSTRACT  
Mucosal-associated invariant T (MAIT) cells produce inflammatory cytokines (IL-17, IFNg, 
TNF), and cytotoxic granzymes in response to by-products of microbial vitamin B2 (riboflavin) 
synthesis. Although MAIT cells are protective against some pathogens, we reasoned that they 
might contribute to pathology in chronic bacterial infection. We have observed MAIT cells in 
proximity to Helicobacter pylori bacilli in human gastric tissue. Here, using MR1 tetramers, we 
examined whether these cells contribute to chronic inflammation in gastritis in a mouse model of 
H. pylori infection. we analysed MAIT cells in chronic Helicobacter pylori SS1 infection. 
Following H. pylori infection of mice, MAIT cells, with an effector memory Tc1/Tc17 phenotype, 
accumulated in the stomach and accelerated gastritis, characterised by the augmented recruitment 
of neutrophils, macrophages, dendritic cells, eosinophils and non-MAIT T cells. This occurred 
both in MAIT TCR transgenic mice, and in wild-type C57BL/6 mice with pre-primed MAIT cells. 
Thus, we demonstrate a pathogenic role for MAIT cells in Helicobacter-associated inflammation, 
revealing a broader potential role for MAIT cell-driven immunopathology in chronic bacterial 
infection. 
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INTRODUCTION 
Mucosal-associated invariant T (MAIT) cells are a subset of T cells, which are abundant in 
humans (1-8% in blood), but relatively rare (about 0.1% in blood) in specific-pathogen-free 
(SPF)-housed laboratory mice (Chen et al., 2017; Martin et al., 2009; Rahimpour et al., 2015; 
Reantragoon et al., 2013). MAIT cells typically express a semi-invariant αβ T cell antigen 
receptor (TCR), which in humans comprises TRAV1-TRAJ33 (Va19-Jα33/20/12) TCR a-chain 
preferentially assembled with TRBV20+ (Vb2) or TRBV6+ (Vb13) TCR b-chain and in mice 
TRAV1-TRAJ33 (Va19-Jα33) paired with TRBV19 (Vb6) or TRBV13 (Vb8) (Lepore et al., 
2014; Reantragoon et al., 2013; Tilloy et al., 1999), and is restricted by the monomorphic Major 
Histocompatibility Complex (MHC) related protein-1 (MR1) (Le Bourhis et al., 2011). 
 MR1 presents vitamin B-based antigens (Ags), including 5-(2-oxopropylideneamino)-6-D-
ribitylaminouracil (5-OP-RU) and 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU), 
which derive from a precursor of microbial riboflavin (vitamin B2) biosynthesis and activate 
MAIT cells in vitro (Corbett et al., 2014; Eckle et al., 2015; Keller et al., 2017a, Mak et al, 2017).  
Indeed, a correlation between the presence of the riboflavin synthesis pathway in diverse 
microbes, including bacteria and yeast, with MAIT cell activation, led to the discovery of this 
pathway as furnishing this new class of antigen (Kjer-Nielsen et al., 2012; Corbett et al., 2014). In 
contrast, microbes that do not synthesise riboflavin, such as Listeria monocytogenes and 
Enterococcus faecalis, do not activate MAIT cells (Gold et al., 2010; Le Bourhis et al., 2010). 
Thus, MAIT cells, which are concentrated in tissues including lungs, intestine and liver, are 
ideally placed to detect metabolically active microbes producing these Ags at mucosal sites.  
In vivo stimulation of MAIT cells with intranasally-delivered synthetic 5-OP-RU, in the 
presence of co-stimulatory signals provided by TLR ligation, led to MAIT cell accumulation in 
the lungs (Chen et al., 2017). MAIT cell non-stimulatory Ags, including 6-formyl pterin (6-FP, a 
folic acid degradation product) and acetyl-6-FP (a derivative) are also presented by MR1 (Kjer-
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Nielsen et al., 2012) and can competitively block MAIT cell activation in vitro (Eckle et al., 2014) 
and in vivo (Keller et al., 2017b). Human and mouse MR1-Ag-tetramers containing 5-OP-RU 
specifically detect MAIT cells in the respective species (Chen et al., 2017; Corbett et al., 2014; 
Reantragoon et al., 2013) without the need for surrogate and potentially misleading MAIT cell 
markers (Chen et al., 2017; Rahimpour et al., 2015).  
 MAIT cells rapidly secrete cytokines (including IFNg, IL-17 and TNF) upon stimulation and 
play a protective role in some bacterial infections, including Klebsiella pneumoniae, 
Mycobacterium tuberculosis, M. bovis BCG and Francisella tularensis (Georgel et al., 2011; 
Meierovics et al., 2013; Meierovics and Cowley, 2016; Sakala et al., 2015). They can also be 
activated in a TCR-independent manner by cytokines or viral infections (Loh et al., 2016; Ussher 
et al., 2014; van Wilgenburg et al., 2016). Correlations between MAIT cell number and disease 
have also been demonstrated for a range of chronic inflammatory conditions suggesting that 
MAIT cells may also contribute to immunopathology as well as protection against microbes. 
These conditions include multiple sclerosis (Held et al., 2015; Miyazaki et al., 2011; Negrotto et 
al., 2015; Salou et al., 2016; Willing et al., 2014), rheumatoid arthritis (Chiba et al., 2012; 
Sugimoto et al., 2015), inflammatory bowel diseases (Haga et al., 2016; Hiejima et al., 2015; 
Serriari et al., 2014; Treiner, 2015), coeliac disease (Dunne et al., 2013) and ankylosing 
spondylitis (Gracey et al., 2016; Hayashi et al., 2016). The basis of these correlative associations 
could involve MAIT cell activation but might also be attributable to treatment (Hinks et al., 2016). 
Indeed, few studies to date have attempted to understand the potential role of MAIT cells in 
immunopathology. We reasoned this might be most likely in unresolved chronic bacterial 
infection and tested this idea in a model of H. pylori gastritis noting that MAIT cell numbers are 
reduced in patients’ blood during H. pylori infection versus healthy controls and human gastric 
MAIT cells can produce cytokines in response to H. pylori (Booth et al., 2015). 
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 H. pylori is a Gram negative extracellular bacterium that colonises the stomach. A large 
proportion of the world’s population is infected with H. pylori, and in most people, unless treated 
with antibiotics, the infection persists for decades. Most infected individuals remain 
asymptomatic, but about 15-20% develop overt disease such as peptic ulcers and severe gastritis. 
A smaller proportion (1-3% of cases) develops gastric adenocarcinoma and fewer again (0.1%) 
mucosal-associated lymphoid tissue (MALT) lymphoma (Peek and Crabtree, 2006). The 
magnitude of the immune reaction to, and the pro-carcinogenic effects of H. pylori are determined 
by both pathogen-derived factors, including well-characterised virulence genes (Ohnishi et al., 
2008; Wada et al., 2004), and host factors, including polymorphisms that lead to high expression 
of the pleiotropic pro-inflammatory cytokine IL-1b, have been linked to increased development of 
hypochlorhydria, gastric atrophy and distal gastric adenocarcinoma in H. pylori infected patients 
(Wroblewski et al., 2010).  
 Infection with H. pylori induces both innate and adaptive immune responses by the host, 
generally T helper (TH) 1-biased, and tempered by regulatory T cells (reviewed in (Larussa et al., 
2015)). The production of pro-inflammatory cytokines, including IL-17 and IFNg by MAIT cells 
(Dusseaux et al., 2011; Meierovics et al., 2013; Rahimpour et al., 2015), suggests their potential to 
play roles in the chronic inflammation (gastritis) that is characteristic of H. pylori infection, and 
possibly in the subsequent development of more severe MALT lymphoma and adenocarcinoma 
that occur in some patients. Since the role of MAIT cells in the immune response to H. pylori 
remains unclear, this circumstantial evidence prompted us to address this question experimentally, 
using Ag-specific MR1 tetramers to detect MAIT cells, thereby removing ambiguity inherent in 
surrogate markers of these cells. 
 Mouse models of H. pylori infection have been widely utilised to understand disease 
development, and show the importance of CD4+ T cells including Th17 cells (Gray et al., 2013; 
Shi et al., 2010). However, to date, no analysis of MAIT cells in mouse models of H. pylori has 
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been reported, perhaps in part due to the low abundance of MAIT cells in mice and low numbers 
of lymphocytes in uninfected stomachs, coupled with a previous paucity of reagents (MR1 
tetramers) to precisely identify murine MAIT cells. Here we use both Va19i.Ca-/- MAIT TCR 
transgenic mice and wild-type C57BL/6 mice with pre-boosted MAIT cells, coupled with the 
capacity to specifically detect MAIT cells using MR1-tetramers, to investigate the role of MAIT 
cells in H. pylori infection, revealing for the first time, their pathogenic role in a chronic bacterial 
infection. 
 
RESULTS 
Helicobacter pylori have a riboflavin-biosynthesis pathway and are capable of activating 
MAIT reporter cells. 
We first tested whether H. pylori synthesise ligands that stimulate MAIT cells. Previously, we 
have shown that both human and mouse MAIT cells are stimulated by ligands, including 5-OP-
RU, formed from the non-enzymatic reaction of a microbial riboflavin biosynthesis precursor with 
small metabolites (Corbett et al., 2014; Kjer-Nielsen et al., 2012). H. pylori and other 
Helicobacter species contain an intact riboflavin synthesis pathway (Kyoto Encyclopedia of 
Genes and Genomes database), and thus were predicted to produce MAIT cell-stimulating 
riboflavin biosynthesis-derived Ags. To verify MAIT cell stimulation by H. pylori, we tested 
culture supernatant from H. pylori SS1 cultures for its ability to stimulate a reporter MAIT cell 
line, Jurkat.MAIT (Kjer-Nielsen et al., 2012). Similar to Salmonella Typhimurium, previously 
shown to stimulate Jurkat.MAIT cells in this assay (Corbett et al., 2014; Kjer-Nielsen et al., 2012; 
Reantragoon et al., 2012), H. pylori culture supernatant caused up-regulation of CD69 on 
Jurkat.MAIT cells in the presence of MR1 expressed on C1R cells (C1R.MR1) (Figure 1a). This 
could be specifically blocked with the anti-MR1 mAb 26.5, but not an isotype control mAb 
(Figure 1a). Importantly, Jurkat cells expressing an irrelevant TCR (Jurkat.LC13) were not 
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activated under the same conditions (Figure 1b). This indicates that H. pylori is capable of 
producing MAIT cell-stimulating Ag. In addition, H. pylori supernatant caused up-regulation of 
MR1 on C1R.MR1 cells (Figure 1c), similar to that previously seen with Salmonella 
Typhimurium supernatant or synthetic 5-OP-RU, 6-FP or acetyl 6-FP (Eckle et al., 2014; Kjer-
Nielsen et al., 2012; Mak et al., 2017), a further confirmation of the presence of MR1-binding Ag. 
 
H. pylori infection in mice increases MAIT cell numbers in the stomach. 
Following human H. pylori infection, only ~20% of individuals develop overt disease. Booth et al. 
(2015) recently reported the presence of MAIT cells in human gastric biopsies and demonstrated 
their capacity to respond to H. pylori-infected macrophages in vitro. Upon examining stomach 
tissue obtained from patients following sleeve gastrectomy bariatric procedures by 
immunofluorescence microscopy in 3 out of 10 cases we observed CD3+TRAV1-2+ cells within the 
gastric mucosa in close proximity to H. pylori (Figure 2). Using MR1 tetramer staining MAIT 
cells could be detected in single cell preparations of gastric tissue where they represented ~1% of 
T cells (Figure 2 and Supplementary Figure 1). Together, the presence of MAIT cells in gastric 
tissue and the ability of H. pylori to activate MAIT cells suggest a potential role for MAIT cells in 
the immune response to H. pylori infection. Notably, analysis of patient samples is complicated by 
the unknown timing and duration of infection, medication history and co-morbidities, such as 
obesity (Magalhaes and Lehuen, 2015) and other conditions. Hence, we directly assessed the role 
of MAIT cells in the well-established mouse model of H. pylori SS1 infection (Lee et al., 1997), 
given its strong similarities to human H. pylori gastric pathology. This allowed us to evaluate the 
behaviour and function of MAIT cells in mouse stomachs following controlled infection in inbred 
mice with a mouse-adapted H. pylori strain.  
MAIT cells are rare in wild-type (wt) C57BL/6 mice compared with humans. For instance, 
they represent <0.5% of T lymphocytes in the stomach of naïve mice, (data not shown). Hence, Commented [II3]: Few too many hences in consecutive 
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following H. pylori infection of wt C57BL/6 mice, we observed that only ~20% (2/10) of animals 
exhibited an increase in proportion of MAIT cells, detected by MR1-tetramers, co-incident with 
gastric pathology (data not shown). We reasoned that increasing mouse MAIT cell numbers to 
resemble the relative numbers found in adult humans might facilitate investigation of their role in 
immune protection or pathology. For this purpose, we turned initially to MAIT TCR transgenic 
mice (Vα19iCα-/-MR1+). These transgenic mice express large numbers of T cells with the canonical 
TCRα chain (Vα19i) characteristic of mouse MAIT cells. They lack the endogenous TCRα chains 
(Cα-/-), thereby eliminating expression of endogenous TCRα (Kawachi et al., 2006). MAIT cells 
from Vα19iCα-/-MR1+ mice are abundant, produce IFNg and TNF and proliferate in vitro in 
response to specific MAIT cell Ag 5-OP-RU (Reantragoon et al., 2013).  
Accordingly, we infected Vα19iCa-/- transgenic mice on MR1+ and MR1-/- backgrounds with H. 
pylori and then isolated single cell suspensions from the stomachs for flow cytometric analysis of 
MAIT cells at several time points. MAIT cells as a proportion of ab-T cells significantly 
increased from ~30% to ~60% at 12 weeks post-infection in the Vα19iCa-/-MR1+ mice as 
compared to the control Vα19iCa-/-MR1-/- mice (Figure 3a, b). Thus, MAIT cells are capable of 
responding not only to H. pylori Ags in vitro, but also to infection in vivo. 
 
An increase in gastric MAIT cells upon H. pylori infection of Vα19iCa-/-MR1+ mice is 
associated with severe pathology. 
We next determined whether MAIT cells accumulating in the stomach in chronic H. pylori 
infection contribute to pathology. Va19iCa-/-MR1+ and Va19iCa-/-MR1-/- were infected with H. 
pylori and stomachs processed for histological assessment by H&E staining at various time points 
after infection. Sections were scored blindly for cellular infiltration (neutrophilic and lymphocytic) 
and atrophy, a classical characteristic of chronic gastritis where there is a loss of chief and parietal 
cells, and a critical step in the development of gastric cancer (Park and Kim, 2015; Rogers, 2012). 
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An increased cellular infiltrate was seen in the stomachs of Va19iCa-/-MR1+ mice relative to 
Va19iCa-/-MR1-/- mice at 12 weeks (Figure 3a, c), consistent with an increase in MAIT cells 
identified by tetramer staining (Figure 3b), and as early as 2 weeks in some mice (not shown). At 
12 weeks post-infection, most Va19iCa-/-MR1+ mice developed severe atrophy (Figure 3c, d), 
suggesting that MAIT cells not only accumulate after infection, but also contribute to pathology.  
 
Prior expansion of MAIT cells in wild-type mice results in greater MAIT cell accumulation 
in stomachs following in H. pylori infection. 
MAIT cell accumulation and enhanced pathology was seen in the Va19i (MAIT TCRa) 
transgenic mice. However, since the ab-T cell repertoire in these mice is unnaturally constrained 
to favour cells expressing only the transgenic Va19Ja33 TCR (Kawachi et al., 2006) and some of 
these T cells do not appear to be MR1-restricted (Sakala et al., 2015), we wished to determine the 
MAIT cell response to H. pylori infection in wt mice. Inbred SPF-housed mice have far fewer 
MAIT cells in the blood than humans, and it has been hypothesised that childhood infections in 
humans boost MAIT cell numbers (Koay et al., 2016). Less than 100 MAIT cells are recoverable 
in single cell suspensions from the stomach of naïve wt C57BL/6 mice (<0.5% stomach T cells), 
compared to ~1-3% in the human gastric mucosa (Booth et al., 2015 and our unpublished 
observations). We reasoned that boosting MAIT cell numbers in wt C57BL/6 mice by prior 
bacterial infection at another mucosal site might expand MAIT cells, and hence reveal their role in 
gastric infection as observed in the Va19iCa-/-MR1+ mice.  
 For this purpose, we used a recently developed model of MAIT cell enrichment in wt C57BL/6 
mice (Chen et al., 2017) that involves either intranasal infection with Salmonella Typhimurium or 
co-inoculation of MAIT Ag and TLR agonists.. Following boosting, MAIT cells rapidly expand in 
an MR1-dependent manner, comprising up to 50% of T cells in the lungs at day 7 post-infection. 
Moreover, MAIT cells were redistributed to other organs and tissues, and their frequencies 
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remained elevated up to 10 weeks post-infection (Chen et al., 2017). Thus, we consider that this 
model more closely resembles MAIT cell distribution in adult humans where a history of infection 
and bacterial colonisation may lead to a greater number of MAIT cells than observed in SPF-
housed mice.  
 In order to determine the effect of boosting MAIT cell numbers on subsequent H. pylori 
infection, wt C57BL/6 mice were infected with S. Typhimurium BRD509 and after 7 weeks, when 
the Salmonella bacteria are cleared, mice were challenged by gastric infection with H. pylori SS1 
(Figure 4a). As expected, prior pulmonary infection with Salmonella not only expanded the 
proportion of MAIT cells in the lungs, and blood of infected mice, but also in the stomachs 
(Figure 4b). Notably, in the stomach, the proportion of MAIT cells increased to approximately 
6% of T cells (Figure 4b). This is similar to human MAIT cell percentages (Booth et al., 2015 and 
our unpublished observations). When these mice were subsequently challenged with H. pylori, 
there was an increase in MAIT cell numbers as early as 2 weeks post-infection with a significant 
increase over time (Figure 4c).  
 
Stomach MAIT cells induced following H. pylori infection exhibit a Tc17/Tc1 profile.  
We next examined the phenotype of the MAIT cells accumulating after H. pylori infection in mice 
that were pre-boosted with S. Typhimurium. MAIT cells isolated from both the lungs and the 
stomach retained an “effector-memory” phenotype, as previously described (Chen et al., 2017; 
Dusseaux et al., 2011), being CD44+ and CD62Llow (Figure 5a). MAIT cells are known to express a 
transcriptional signature that includes the regulators PLZF, RORgt and T-bet. We found that 
stomach MAIT cells showed a mixture of PLZF+ and PLZF-, as well as RORgt+ and RORgt- cells. 
T-bet was expressed on the majority of MAIT cells, 8 weeks post H. pylori infection (Figure 5b 
and Supplementary Figure 2). There was a preferential accumulation of CD8+ MAIT cells in the 
stomach (Figure 5c), and the majority of MAIT cells expressed CD69 and CD103, consistent with 
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a tissue-resident phenotype (Booth et al., 2015) (Figure 5d). This was also true for non-MAIT ab-
T cells accumulating in the stomach after 8-weeks of infection with H. pylori. Multiplex PCR and 
sequencing of single cells showed a TCR repertoire consistent with MAIT cells (Supplementary 
Table 1). Thus, MAIT cells accumulating in the stomach after H. pylori infection have a 
transcription factor profile consistent with Tc17/Tc1 type cells characteristic of pro-inflammatory 
capability. 
 
MAIT cells are important for early recruitment of other T cells. 
In order to understand the implications of MAIT cell accumulation during gastric infection, we 
examined the effect of MAIT cell induction on the non-MAIT ab-T cell response. In pre-primed 
mice the increase in MAIT cells was also accompanied by an increase in non-MAIT αβ-T cells. 
This effect was not observed in mice lacking MR1 (C57BL/6.MR1-/-), indicating that it was MR1-
dependent and therefore likely to be a MAIT cell-driven (Figure 6a). We have previously shown, 
both in vitro and in vivo, that MAIT cell responses are dependent on microbial riboflavin 
metabolites (Chen et al., 2017; Corbett et al., 2014; Kjer-Nielsen et al., 2012). Mice infected with 
a mutant strain of S. Typhimurium BRD509 in which key genes involved in riboflavin synthesis, 
ribD and ribH, are deleted (Salm.DribDH) (Chen et al., 2017) did not accumulate MAIT cells in 
their stomachs following subsequent H. pylori infection (Figure 6b). However, the response could 
be rescued when BRD509DribDH was supplemented with synthetic 5-OP-RU ligand (Mak et al., 
2017) (Figure 6b). The non-MAIT ab-T cell accumulation was also partially dependent on the 
presence of 5-OP-RU, supplied either by adding riboflavin-producing S. Typhimurium BRD509 
bacteria or by adding exogenous synthetic ligand (Figure 6c). Similar to our previous 
observations in the lung model (Chen et al., 2017), this result could be reproduced by intranasal 
introduction of specific MAIT cell antigen 5-OP-RU and a co-stimulus, such as the TLR2/6 
agonist S-[2,3-bis(palmitoyloxy)propyl] cysteine (Pam2Cys) (Jackson et al., 2004; Lau et al., 
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2006). In contrast, non-MAIT ab-T cell accumulation was much less apparent when Pam2Cys 
was combined intranasally with the MR1 ligand 6-FP, which does not stimulate MAIT cells (Kjer-
Nielsen et al., 2012) (Figure 6d, e). Thus, Ag-specific priming of MAIT cells leads to 
accumulation of non-MAIT T cells in the stomach upon H. pylori infection. 
 
Recruitment of other immune cells via MAIT cells leads to accelerated pathology. 
T cells and other cell types, including neutrophils and macrophages, have been implicated in 
pathology (gastritis) following H. pylori infection in humans and mouse models (Kaparakis et al., 
2008; Moyat and Velin, 2014). In mice pre-primed with either S. Typhimurium BRD509 or 
Pam2Cys plus 5-OP-RU, and then challenged with H. pylori, we observed, in addition to MAIT 
cell (Figure 4c) and non-MAIT ab-T cell (Figure 6a) accumulation, an increase in other immune 
cells including neutrophils, macrophages, eosinophils and dendritic cells (Figure 7a-d). This 
increase was significantly higher than in MR1-/- mice, indicating a role for MAIT cells in the 
recruitment of other cell types. The MAIT cell accumulation and recruitment of other cell types 
was associated with gastritis, which was evident on H&E-stained stomach sections 
(Supplementary Figure 3), and in significantly increased pathogenic scores, compared to MR1-/- 
mice, for lymphocytic infiltrate and atrophy. Strikingly, all MAIT pre-boosted mice infected with 
H. pylori developed atrophic gastritis by 8 weeks post-infection (Figure 7e); comparatively, only 
2/5 mice developed atrophic gastritis (score 1/4) in the absence of MR1. Gastritis was also 
observed following H. pylori infection in wt mice primed with riboflavin-deficient S. 
Typhimurium (Salm.DribDH) or Pam2Cys, but this was significantly increased when the specific 
MAIT antigen 5-OP-RU was also added (Supplementary Figure 4), further demonstrating that 
MR1-Ag dependent MAIT activation is a driver of gastric pathology. 
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DISCUSSION 
We and others (Booth et al., 2015) have observed the presence of MAIT cells in human gastric 
mucosae, prompting us to examine the role of MAIT cells in chronic H. pylori infection, with the 
use of an established mouse infection model supported by detection of MAIT cells using Ag-
specific MR1-5-OP-RU-tetramers. Given that MAIT cells were virtually undetectable in stomachs 
of SPF-housed wt C57BL/6 mice, we used two methods to boost MAIT cell numbers to ‘human-
like’ proportions prior to challenge with H. pylori, on the basis that prior expansion of these cells 
is integral to their impact. First, we used Va19iCa-/-MR1+ TCR transgenic mice, where a rapid, 
MR1-dependent, expansion of MAIT cells was observed following infection that led to early and 
severe atrophic gastritis. This observation strongly suggested the association of MAIT cells and 
pathology. 
 Secondly, we built upon our previous studies showing that MAIT cells are distributed to many 
different tissues and organs after resolution of a primary lung infection (Chen et al., 2017).  We 
hypothesized that a previous history of infection of this kind can prime MAIT cells in naïve mice 
and increase their numbers to a level similar to that in humans. Indeed, we observed increased 
MAIT cells in the stomach after a primary lung infection, possibly due to mucosal homing 
markers expressed on MAIT cells and a shared cytokine/chemokine milieu between the mucosae 
of the lungs and stomach (Flach et al., 2012; Kohlmeier et al., 2011).  
 We show that when MAIT cells from wild type C57BL/6 mice are primed first with S. 
Typhimurium, or with specific antigen and a co-stimulus, they subsequently respond rapidly upon 
challenge with H. pylori (~10 fold increase at 2 weeks post-infection) and these mice develop 
severe inflammation, recapitulating what was observed with the MAIT TCR transgenic mice. 
These mice developed atrophic gastritis as early as 8 weeks post-infection, which is normally not 
observed in wt C57BL/6 mice infected with H. pylori. The response was specific to MAIT cells 
and dependent on MR1. The accumulation of MAIT cells in the stomach showed a biased 
Deleted: ways 
Deleted: naive
Deleted: the 
Commented [II4]: This is not clear – clarify the ten fold 
increase – of what? Accumulation? Doesn’t quite make sense 
as written. Disconnect between “They respond rapidly” and 
“10 fold increase” Need 2 short sentences here. 
 
Deleted: seen 
 14 
enrichment of CD8+ MAIT cells that was not seen in the blood. This could be due to up-regulation 
of CD8 on the same MAIT cell population, as the cytokine milieu has been shown to influence 
CD8 expression on CD4+ T intraepithelial lymphocytes (Reis et al., 2013), or it might reflect 
preferential expansion of CD8+ MAIT cells.  
 Consistent with other mouse and human studies on MAIT cells (Booth et al., 2015; Chen et al., 
2017; Dusseaux et al., 2011), we observed that MAIT cells in the stomach have an effector 
memory phenotype, characterised by CD44hi CD62Llo expression. A large proportion (~50-70%) 
expressed the tissue resident memory (TRM) markers CD69 and CD103, consistent with 
observations on cells isolated from H. pylori-infected stomachs (Booth et al., 2015), and reflecting 
the chronic nature of H. pylori infection. MAIT cells isolated from infected stomachs also showed 
high expression of T-bet, consistent with a Th1-biased immune response to H. pylori and similar 
to that observed after acute bacterial lung infection (Chen et al., 2017). Interestingly, T-bet 
deficient mice exhibit a higher bacterial load, but lower levels of gastritis after H. pylori infection, 
indicating that a Th1-biased response may be important for both protection and immunopathology 
(Eaton et al., 2006). PLZF and RORgt were each expressed on ~50% of stomach MAIT cells 
following H. pylori infection of primed mice. Although MAIT cells in the stomachs of naïve mice 
were too few to be included in this analysis, the lower expression of these transcription factors 
following infection differs from that seen previously in either naïve or S. Typhimurium-infected 
lungs, where the majority of MAIT cells expressed PLZF and RORgt (Chen et al., 2017). This 
difference may result from re-programming of MAIT cell cytokine profiles, preferential expansion 
of MAIT cell subsets under different tissue-specific cytokine milieu during chronic stimulation, or 
other signals that differ between the two pathogens. Interestingly, natural killer T cells can down-
regulate PLZF in adipose tissue due to chronic activation (Lynch et al., 2015). To our knowledge, 
this is the first description of such a marked shift in the expression pattern of these transcription 
factors by MAIT cells, and the first demonstration of enrichment of Tc1/Th1 MAIT cells. 
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 A number of studies using a range of mouse models have shown a Th1/Th17 type of T cell 
response in H. pylori (Gray et al., 2013). The pro-inflammatory cytokines TNF, IFNg and IL17 are 
known to play an important synergistic role in regulating polymorphonuclear leukocyte migration 
in an inflammatory setting (Cua and Tato, 2010; Ellis and Beaman, 2004; Griffin et al., 2012). 
MAIT, and to a lesser extent non-MAIT ab-T cells in our study, showed mixed RORgt+ and 
RORgt– populations and high T-bet expression. Although technical difficulties precluded detection 
of cytokine production by stomach MAIT cells, the high T-bet expression suggests MAIT cells 
likely express IFNg in H. pylori-infected stomachs, consistent with a role for this cytokine in 
driving pathology. Importantly, we also showed that the presence of MAIT cells correlated with 
infiltration of innate immune cells, as well as increased recruitment of non-MAIT ab-T cells. This 
recruitment is associated with the severe gastritis phenotype observed in the wild-type C57BL/6 
with pre-boosted MAIT cells, and MAIT TCR transgenic mice infected with H. pylori. Indeed, 
previous studies have shown that T cells are major orchestrators of inflammation (Gray et al., 
2013; Shi et al., 2010; Tan et al., 2008). Interestingly, IFNg- and IL-17A-deficient mice exhibited 
reduced gastritis in previous H. pylori infection studies, consistent with a role for MAIT or other 
cell types in orchestrating pathology (Yamamoto et al., 2004).  
 In summary, we show that in H. pylori-induced gastritis, MAIT cells play a pathogenic role in 
orchestrating immunopathology. This study provides the first in vivo evidence that MAIT cells can 
drive inflammation and pathology during chronic bacterial infection. It is likely that the 
penetrance of gastritis in H. pylori-infected humans is partly influenced by a previous history of 
infections, and MAIT cell priming at other mucosal sites. The recognition of a common MR1-
retricted Ag, derived from bacterial riboflavin synthesis, suggests that MAIT cells represent a 
potential therapeutic target to modulate inflammation in other chronic bacterial infections. Our 
findings also underscore a potential risk of vaccination, such as with S. Typhi (Salerno-Goncalves 
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et al., 2017), which might activate MAIT cells and predispose an individual to subsequent 
immunopathology.  
 
MATERIALS AND METHODS 
Human gastric tissue and immunofluorescence staining. Human gastric tissue, normally 
discarded following sleeve gastrectomy bariatric surgery was obtained through The Avenue 
Hospital, Melbourne with written consent from patients, as per Ethics Approval #1442531 from 
The University of Melbourne and #187 from The Avenue Human Research Ethics Committees. 
All patients were female, between 27-57 years of age. Gastric mucosa was dissected from 
underlying tissue, rinsed with ice-cold HBSS, snap frozen in OCT and sectioned (8 µm) using a 
Leica CM3050 S cryostat. Acetone-fixed tissue was blocked with Serum-Free Protein Block 
(DAKO, Denmark) for 30 min and/or 10% goat serum (Sigma, Missouri, USA) at RT, prior to 
detection with primary antibodies targeting CD3 (CD3-12, Bio-Rad), TRAV1-2 (3C10, 
Biolegend, CA, USA) and H. pylori rabbit polyclonal (DAKO) diluted in 2.5% normal goat 
serum, followed by Alexa Fluor 647-Goat anti Rat, Alexa Fluor 488-Goat anti Mouse and Alexa 
Fluor 555-Goat anti Rabbit secondary antibodies, respectively (Life Technologies, CA, USA). 
Nuclei were counter-stained with Hoechst 33342 (Life Technologies) prior to mounting with 
ProlongGold (Life Technologies). Slides were analysed using Carl Zeiss LSM700 confocal 
microscope with a 20x and 100x objectives and Carl Zeiss Zen software. Images were prepared 
using FIJI/Image J software.  
 
PBMC and gastric cell preparations and flow cytometry 
Tissue was transferred to 30 ml EDTA/BSS + 5% FCS + 1 mM DTT, chopped into 2-5 mm 
pieces, then incubated shaking at 150 rpm, 15 min, 37 °C.  Cells dissociated from tissue were 
passed through a 70 µm strainer, washed in EDTA/BSS + 5% FCS. Patient PBMCs were prepared 
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by Ficoll-Plaque density gradient separation from ~20 ml fresh blood. Both gastric and blood cells 
were frozen in FCS + 10% DMSO and stored in liquid N2 until use. Upon thawing, cells were 
washed, rested for 1-2 hours then filtered (70 µm). Cells (3x105 to 3x106) were incubated in 
viability stain Live/Dead Aqua (ThermoFisher 1:500) for 30 min, at RT, before staining with Ab 
to CD3 (OKT3 AF700, eBioscience), CD45 (HI30, BV605, BioLegend), CD161 (HP-3G10, PE-
Cy7, BioLegend) and human MR1-5-OP-RU-tetramer (PE), and were fixed with 1% 
paraformaldehyde before analysis on a BD LSR Fortessa Flow Cytometer (BD Biosciences). Data 
was analysed with FlowJo software (Treestar, v10). 
 
Activation of Jurkat.MAIT cells and MR1 upregulation. MAIT cell reporter activation and 
MR1 expression upregulation assays were performed essentially as previously reported (Kjer-
Nielsen et al., 2012). Jurkat cells overexpressing the MAIT TCR clone AF-7 (Jurkat.MAIT), were 
tested for activation by co-incubation with compounds and C1R antigen presenting cells over-
expressing MR1 (CIR.MR1) for 16 h. Cells were subsequently stained with PE-Cy7-conjugated 
anti-CD3 (UCHT1, eBioscience, 1:300), and APC-conjugated anti-CD69 (BD, 1:25) before 
analysis by on a FACS CantoII (BD) flow cytometer. Activation of Jurkat.MAIT was measured by 
an increase in surface CD69 expression. In some activation experiments, blocking antibody 
(prepared in house from hybridoma anti-MR1 mAb 26.5, a gift from Dr. Ted Hansen, Washington 
University School of Medicine, St. Louis, MO (Chua et al., 2011)) or isotype control 8A5 
(prepared in-house) were added (final 10 µg/ml) prior to addition of the test supernatants. For 
MR1 expression, cells were additionally stained with biotinylated anti-MR1 mAb 26.5, followed 
by PE-conjugated streptavidin. Control Jurkat.LC13 cells (Kjer-Nielsen et al., 2012) utilizing 
alpha chain TRAV26-2 and beta chain TRBV7-8 were activated by C1R cells expressing HLA-B8 
in the presence of the Epstein-Barr viral peptide FLRGRAYGL (FLR). 
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Compounds and immunogens. 5-OP-RU was prepared as described previously (Mak et al., 
2017). 6-FP was purchased from Schirks Laboratories (place?). TLR2/6 agonist Pam2Cys (Tan et 
al., 2012) was chemically synthesized and functionally verified. CpG1688 (Sequence: 
T*C*C*A*T*G*A*C*G*T*T*C*C*T*G*A*T*G*C*T (*phosphorothioate linkage) non-
methylated cytosine-guanosine oligonucleotides was purchased from Geneworks (Australia). Poly 
(I:C) (HMW VacciGrade) was purchased from InvivoGen (USA). 
 
Mice. All C57BL/6 mice, MR1-/- mice, Vα19iCα-/-MR1+ and Vα19iCα-/-MR1-/- (all on C57BL/6 
genetic background) were bred and housed in the Biological Research Facility of the Peter 
Doherty Institute for Infection and Immunity, University of Melbourne. MR1-/- mice were derived 
from Vα19iCα-/-MR1-/- mice (Kawachi et al., 2006) obtained from Susan Gilfillan (Washington 
University in St. Louis School of Medicine, St. Louis, MO). MR1-/-, mice were generated by 
breeding Vα19iCα-/-MR1-/- mice with C57BL/6 mice, and inter-crossing of F1 mice. The genotype 
was determined by tail DNA PCR at the MR1 locus and by analyzing blood for the presence of 
intact ab-T cells using antibodies against TCRb. The phenotype (absence of MAIT cells) of the 
MR1-/- mouse line was verified by examining MAIT cells in the retired founder breeder mice. 
Female mice aged between 6-12 weeks were used in all experiments. All procedures on mice were 
conducted after approval by the University of Melbourne Animal Ethics Committee. 
 
Bacterial culture and infection. Helicobacter pylori SS1 (Lee et al., 1997) was cultivated as 
described previously (McGuckin et al., 2007). Mice were infected orogastrically with  H. pylori 
(107 cfu) suspended in 100 µL brain heart infusion broth (BHI). Salmonella enterica serovar 
Typhimurium BRD509 (Hoiseth and Stocker, 1981; Newland et al., 1992) and the S. 
Typhimurium BRD509ΔribDH mutant (Chen et al., 2017) have been previously described. For S. 
Typhimurium ΔribDH growth, culture medium was supplemented with 20 µg/ml riboflavin. Mice 
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were inoculated under isofluorane anaesthesia with S. Typhimurium BRD509 (106 cfu) or ΔribDH 
(107 unless otherwise stated) or Ags (1.52 µM 5-OP-RU or 6-FP alone in 50 µl, or in 45 µl plus 5 
µl of 20 nmol Pam2Cys) prepared in 50 µl PBS, via the intranasal route. 
 
Preparation of organs and isolation of cells. Single cell suspensions of lungs, blood, mesenteric 
lymph nodes, and spleen were prepared as described previously (Chen et al., 2017). Gastric 
immune cells were isolated by perfusion from longitudinally halved stomachs, as described 
previously (Ng and Sutton, 2015).  
 
Generation of MR1 tetramers. Mouse or human MR1 and β2-Microglobulin proteins were 
expressed in E. coli inclusion bodies, refolded and purified as described previously (Patel et al., 
2013). MR1-5-OP-RU labelled with BV-421 and MR1-6-FP (unlabelled) tetramers were 
generated as described previously (Corbett et al., 2014) and prepared simultaneously. 
 
Antibodies and flow cytometry. Antibodies against CD19 (1D3, PerCP-Cy 5.5), CD3 (UCHT1, 
PE or 145-2C11, PE-Cy7) CD4 (GK1.5, APC-Cy7), CD45.2 (104, FITC), CD69 (FN50, APC) 
CD8α (53-6.7, PE), TCRβ (H57-597, APC or FITC) were purchased from BD?. Antibodies 
against MHC II (M5, AlexaFluor700), PLZF (Mags.21F7, PE), RORgt (B2D, APC) and T-bet 
(4B10, PE-Cy7) were purchased from eBioscience. To block non-specific staining, cells were 
incubated with MR1-6-FP tetramer (unlabelled, 1:100) and anti-Fc receptor (2.4G2) for 15 min at 
RT prior to antibody staining. Cells were then incubated at RT with antibody cocktails including 
MR1-5-OP-RU tetramer in PBS/2% FCS. Cells were then further incubated with 7-
aminoactinomycin D (5 µl/sample) for 10 min in the dark at RT and fixed with 1% 
paraformaldehyde prior to analysis on LSR Fortessa (BD Bioscience). Data was analysed with 
Flowjo X 10 software (Treestar). Cell counts were obtained using blank calibration particles (BD 
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Pharmingen). Transcription factor staining was performed using a commercial transcription buffer 
staining set (eBioscience) according to the manufacturer’s instructions. 
 
Assessment of gastritis. Longitudinally dissected half stomachs were fixed in 10% neutral 
buffered formalin, embedded in paraffin; 5 μm sections were stained with H&E and scored by a 
blinded operator under light microscopy. A pathologist also scored sections independently and the 
grading system is based on a previously described system (Sutton et al., 2001) with modifications. 
Briefly, inflammation was assessed in two separate tissue sections for each animal using 3 
parameters: (i) neutrophil infiltration and (ii) lymphocyte infiltration: scored from 0 - 4 on the 
basis of number of cells and whether widespread or multifocal infiltrate was observed, and (iii) 
atrophy: scored from 0-4 on the basis of percentage loss of chief and parietal cells from the gastric 
glands.  
 
PCR amplification and sequencing of TCR repertoire. Single cells were sorted from S. 
Typhimurium BRD509-primed, H. pylori-infected C57BL/6 mouse stomachs on a FACSAria flow 
cytometer. PCR amplification and TCR sequencing was performed as previously described 
(Reantragoon et al., 2013; Wang et al., 2012).  
 
Statistical analysis. Statistical tests were performed using Prism software (version 6, GraphPad 
software, La Jolla, CA, USA). Comparisons between groups were performed using one-way 
ANOVA, Student’s t test or Kruskal-Wallis test (histopathology scores)..  
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FIGURE LEGENDS 
Figure 1. H. pylori culture supernatant stimulates a MAIT cell line. A) In vitro activation of 
Jurkat.MAIT cells by filtered S. Typhimurium SL1344 (Salm., grey bars) or H. pylori SS1 (black 
or dotted bars) supernatant (s/n) or media controls (LB or BHI respectively, striped bars) in a co-
culture assay with C1R.MR1 cells with or without MR1 blockade (mAb 26.5 or isotype control 
8A5). Activation was detected by staining with anti-CD69. B) Activation of control Jurkat.LC13 
cells cultured with C1R.HLA-B8 cells with H. pylori s/n (black bars) or 285nM FLRGRAYGL 
peptide from Epstein Barr Virus (FLR, grey bar). Data shows MFI (mean ± SEM) of gated 
Jurkat.MAIT or Jurkat.LC13 cells from three independent experiments. C) MR1 expression on 
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gated C1R.MR1 cells following overnight incubation with H. pylori s/n or BHI media. Data shows 
MF1 minus background (Nil stimulus) (mean ± SEM from three experiments). 
 
Figure 2. MAIT cells are observed in human gastric mucosa in proximity to H. pylori. A) 
Immunofluorescence staining of human gastric tissue. Magenta: CD3, Grey: TRAV1-2, Yellow: 
H. pylori, Blue: nuclear stain. 100 x magnification. Blue arrows CD3+TRAV1-2+ cells, Yellow 
arrow: H. pylori. Multiple sections from three patients showed similar results. B) Detection of 
MAIT cells by flow cytometry in PBMCs or single cell suspensions of gastric tissue from patients 
undergoing sleeve gastrectomy. Gate shows MAIT cells, defined as CD3+CD45+CD161+MR1-
tetramer+ live cells. Numbers indicate the MAIT cell percentage of CD3+CD45+ live cells. 
 
Figure 3. MAIT TCR transgenic mice show greater pathology following H. pylori infection. A) 
Representative plots showing MAIT and non MAIT CD3+ cells in Va19iCα-/-MR1+ and Va19iCα-/-
MR1-/- mice at 12 weeks post-infection with H. pylori. B) MAIT cells as a percentage of CD3+ T 
cells in Va19iCα-/-MR1+ and Va19iCα-/-MR1-/- mice over a time course of 2 to 12 weeks post-
infection. The experiment was performed three times with similar results: 5-8 mice per group were 
examined (mean ± SEM, one-way ANOVA, **p<0.001). C) Pathology scores of Vα19iCα-/-MR1+ 
and Vα19iCα-/-MR1-/- mice at 12 weeks post infection. Sections were scored for neutrophilic 
infiltration, lymphocytic infiltration and atrophy (Kruskal-Wallis test, *p<0.05). D) Representative 
photomicrographs of H&E-stained sections of mouse stomachs showing infected Vα19iCα-/-MR1+ 
with severe gastritis, uninfected Vα19iCα-/-MR1+ (normal) and infected Vα19iCα-/-MR1-/- (normal 
architecture). 
 
Figure 4. MAIT cells expand in response to H. pylori infection in wt C57BL/6 mice after pre-
priming. A) Schematic depicting the model used for the experiments. B) Percentage distribution of 
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MAIT cells in different organs 7 weeks after intranasal infection with S. Typhimurium BRD509. 
C) Absolute numbers of MAIT cells from the stomachs of wt mice infected with S. Typhimurium 
BRD509, and then challenged (at 7 weeks) with H. pylori or left unchallenged over time (one-way 
ANOVA, *p<0.05, **p<0.001; n=8).  
 
Figure 5. Characterisation of the phenotype of MAIT cells following infection. Analysis of 
effector memory (CD62L and CD44) (A), and tissue residency (CD103 and CD69) marker 
expression (D) on MAIT cells and non-MAIT T cells isolated from the lungs and stomachs of S. 
Typhimurium-primed mice infected with H. pylori, (or left uninfected) at 8 weeks post-infection. 
(B) Transcription factor expression by MAIT cells and non-MAIT T cells isolated from the 
stomachs of S. Typhimurium-primed H. pylori-infected mice at 8 weeks post-infection. C) CD4+, 
CD8+ and DN MAIT cells expressed as a percentage of total MAIT cells in the blood and stomachs 
of S. Typhimurium-primed mice, challenged or not with H. pylori at 8 weeks post H. pylori 
infection. The experiments were performed three times with similar results. Representative plots 
are shown. 
 
Figure 6. MAIT cells orchestrate accumulation of other T cells in the gastric mucosa. A) Absolute 
numbers of non-MAIT αβ-T cells from the stomachs of wt and MR1-/- mice infected with S. 
Typhimurium BRD509 (Salm.), and then challenged (at 7 weeks) with with H. pylori or left 
unchallenged over time (one-way ANVOA, *p<0.05, **p<0.001; n=8). Data is from the same 
experiment shown in Fig. 4c. B-E) Absolute numbers of MAIT cells (B, D) and non-MAIT αβ-T 
cells (C, E) from stomachs of wt and MR1-/- mice primed with S. Typhimurium BRD509 (Salm.) 
or BRD509ΔribDH (Salm.ΔribDH) plus or minus 5-OP-RU (B-C) or Pam2Cys plus either 5-OP-
RU or 6-FP (D-E), and then either challenged with H. pylori or left unchallenged (data shown is 8 
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weeks post-H. pylori infection) (one-way ANOVA, *p<0.05, **p<0.001). The experiment was 
performed twice with similar results. Data represent mean ± SEM (n=5-8). 
 
Figure 7. Prior expansion of MAIT cells leads to recruitment of innate immune cells in wt mice 
and reveals pathological role in H. pylori infection. Absolute numbers of neutrophils (A), 
macrophages (B), eosinophils (C), and dendritic cells (D) from stomachs of wt and MR1-/- mice 
infected with S. Typhimurium BRD509 (Salm.) or Pam2Cys plus 5-OP-RU, and then challenged 
with H. pylori (at 7 weeks) or left unchallenged over time (one-way ANOVA, *p<0.05, 
**p<0.001; n=8). (E) Pathology scores of S. Typhimurium-primed wt and MR1-/- mice at 8 weeks 
post H. pylori infection. Sections were scored for neutrophilic infiltration, lymphocytic infiltration 
and atrophy (Kruskal-Wallis test, *p<0.05). Representative scores from one experiment are 
shown. The experiment was repeated 3 times with similar results. 
 
Supplementary Figure 1. Gating strategy for flow cytometry of PBMCs and gastric cell 
suspensions. Cells were gated sequenctially from left to right for lymphocytes, single cells, live 
cells, CD45+CD3+ cells, and finally MAIT cells.  
 
Supplementary Figure 2. Scatter plots showing MAIT cell transcription factor expression from 
lung or, stomach MAIT cells from primed or primed and challenged mice (each dot represents 
data from 2-3 pooled mice).  
 
Supplementary Table 1. Table of representative stomach TCR sequences identified from single 
sorted MAIT cells and multiplex PCR sequencing (n=30). Cells were obtained from stomachs of 
S. Typhimurium BRD509-primed and H. pylori-challenged wt mice at 2 weeks post H. pylori 
infection.  
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Supplementary Figure 3. Representative photomicrographs of H&E-stained sections of mouse 
stomachs from wt mice immunised with S. Typhimurium BRD509 (Salm.) (showing normal 
mucosa) and primed with S. Typhimurium BRD509 (Salm.) and H. pylori-challenged wt (severe 
gastritis) and MR1-/- mice (mild inflammation). 
 
Supplementary Figure 4. Pathology scores of wt and MR1-/- mice primed with S. Typhimurium 
BRD509 (Salm.) or BRD509ΔribDH (Salm.ΔribDH) (A) or Pam2Cys and 5-OP-RU or 6-FP (B) 
then challenged with H. pylori or left unchallenged at 8 weeks post H. pylori-infection. Sections 
were scored for neutrophilic infiltration, lymphocytic infiltration and atrophy (Kruskal-Wallis test, 
*p<0.05). 
 
 
